Results 51 to 60 of about 13,105 (215)
ABSTRACT Background Data comparing clinical and hemodynamic outcomes of bioprosthetic valve fracturing (BVF) and “standard”‐postdilatation during valve‐in‐valve transcatheter heart valve implantation (ViV‐TAVI) are lacking. The authors aimed to analyze hemodynamic and clinical outcomes of BVF compared to “standard”‐postdilatation during ViV‐TAVI ...
Hendrik Ruge +14 more
wiley +1 more source
Restoration of a Stuck Leaflet
ABSTRACT Severe aortic regurgitation (AR) for a leaflet malfunction after transcatheter aortic valve implantation (TAVI) is a dreadful complication that can lead even to cardiogenic shock. New valve's design has reduced the rate of paravalvular regurgitation, however central regurgitation is still a challenging complication.
Elisa Tomarelli +3 more
wiley +1 more source
Abdominal wall repair with acellular bovine pericardial membranes - Part I - Clinical and radiological findings [PDF]
Introduction: Reducing recurrence rates significantly, the use of biomaterials as “reinforcement meshes” in the repair of different abdominal wall defects has become an almost mandatory routine for the success of these repairs.
Luiz Fernando Frascino +3 more
doaj +1 more source
ABSTRACT Background Little is known about the clinical and hemodynamic outcome of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR) for failed Trifecta surgical aortic bioprotheses. Aims We aimed to compare outcomes of valve‐in‐valve transcatheter aortic valve replacement (ViV‐TAVR into failed TrifectaTM vs.
Matthias Raschpichler +9 more
wiley +1 more source
ABSTRACT Various biomaterials are currently used in clinical settings for heart valve repair and replacement. However, the optimal tissue preparation technique remains elusive. In this study, a non‐crosslinked tissue obtained from bovine pericardium, developed by Adeka Corporation, was compared with three commercially‐available tissues: two fixed ...
Danila Vella +11 more
wiley +1 more source
Background. Redo operation for failed tricuspid bioprosthetic valves is associated with high morbidity and mortality. Transcatheter tricuspid valve-in-valve implantation has become an acceptable option for high-risk patients with a failed tricuspid ...
Mingkui Zhang +4 more
doaj +1 more source
ABSTRACT Background Hypoattenuated leaflet thickening (HALT) after transcatheter aortic valve implantation (TAVI) detected on multidetector computed tomography (MDCT) is considered leaflet thrombosis. However, its impact on long‐term clinical outcomes remains unclear. This study aimed to investigate the impact of early HALT detection after TAVI on long‐
Juri Iwata +15 more
wiley +1 more source
ABSTRACT Background and Aims Percutaneous pulmonary valve implantation was introduced two decades ago as a low‐risk alternative for patients previously operated with conduits presenting RVOT dysfunction. Recently, Sapien valve was approved for use in the pulmonary position but this valve cannot be used for RVOT larger than 29 mm.
João Luiz Langer Manica +13 more
wiley +1 more source
ABSTRACT Transcatheter mitral valve replacement (TMVR) may emerge as a surgical alternative for high‐risk patients with severe mitral annular calcification (MAC), yet several questions remain to be addressed. We present the case of a 67‐year‐old high‐risk female patient with severe MAC (MAC score = 8) and mitral stenosis (effective orifice area = 121.3
Yiwei Wang +3 more
wiley +1 more source
Background Aortic valve replacement (AVR) is one of the most common surgeries performed in cardiac surgery operating rooms. We present actual, real life trends from the last 10 years for AVR interventions based on a multicentre National Registry of ...
K. Bartus +14 more
semanticscholar +1 more source

